We are live on ! Find out more
NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.23B
1-Year Est. Return 81.32%
This Fund
S&P 500
This Quarter Est. Return
+21.73%
1 Year Est. Return
+81.32%
3 Year Est. Return
+192.63%
5 Year Est. Return
+125.03%
10 Year Est. Return
+943.65%
AUM
$1.55B
AUM Growth
+$969M
Cap. Flow
+$774M
Cap. Flow %
49.87%
Top 10 Hldgs %
88.53%
Holding
32
New
3
Increased
3
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$678M
2
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
+$41.6M
3
BN icon
Brookfield
BN
+$37.6M
4
CABO icon
Cable One
CABO
+$26.9M
5
SPRO icon
Spero Therapeutics
SPRO
+$5.02M

Top Sells

Rank Stock Value
1
KIDS icon
OrthoPediatrics
KIDS
+$5.33M
2
XLRN
Acceleron Pharma
XLRN
+$4.73M
3
MIST icon
Milestone Pharmaceuticals
MIST
+$4.25M
4
COGT icon
Cogent Biosciences
COGT
+$682K

Sector Composition

Rank Sector Weight
1 Healthcare 37.72%
2 Communication Services 6.13%
3 Technology 5.06%
4 Financials 2.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYOK
26
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$2.21M 0.14%
30,348
– –
BHVN
27
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.95M 0.13%
35,900
– –
ZGNX
28
DELISTED
Zogenix, Inc.
ZGNX
$1.86M 0.12%
35,700
– –
COGT icon
29
Cogent Biosciences
COGT
$7.14B
– –
-118,360
Closed -$682K
KIDS icon
30
OrthoPediatrics
KIDS
$586M
– –
-151,259
Closed -$5.33M
XLRN
31
DELISTED
Acceleron Pharma
XLRN
– –
-119,708
Closed -$4.73M
1
2

Similar funds

HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
WCM
Windward Capital Management Los Angeles, California $1.23B AUM 23.17% 1-Year Est. Return
IA
Inspire Advisors Meridian, Idaho $1.23B AUM 18.62% 1-Year Est. Return
HTHT
Hemenway Trust Hemenway Trust Salem, New Hampshire $1.24B AUM 16.52% 1-Year Est. Return

Novo Holdings A/S's Q4 2019 Portfolio in Review

As of Q4 2019, Novo Holdings A/S held 32 positions worth $1.55B, up 166% from $584M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Novo Holdings A/S deployed $774M of net new capital in Q4 2019, opening 3 new positions and adding to 3 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 4,325,200 shares worth $708M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 73% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Milestone Pharmaceuticals, an estimated $4.25M trimmed.

  • Novo Holdings A/S's largest Q4 2019 buy was Vanguard Morningstar Total Stock Market ETF: 4,325,200 shares worth $708M.
  • Novo Holdings A/S added most to Cable One in Q4 2019, an estimated $26.9M increase.
  • Novo Holdings A/S's biggest Q4 2019 reduction was Milestone Pharmaceuticals, cutting an estimated $4.25M.
  • Novo Holdings A/S fully exited OrthoPediatrics in Q4 2019, selling an estimated $5.33M.
  • Novo Holdings A/S's ten largest holdings make up 89% of its $1.55B portfolio in Q4 2019.
  • Novo Holdings A/S opened 3 new positions and closed 3 in Q4 2019.
  • Novo Holdings A/S's portfolio value rose 166% quarter-over-quarter to $1.55B.

Based on Novo Holdings A/S's 13F filing for Q4 2019, filed 14 Feb 2020.